EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prostacyclin and heparin during hemodialysis comparative effects






Life Support Systems 4(3): 205-209

Prostacyclin and heparin during hemodialysis comparative effects

Haemodialysis was performed using heparin (dialysis I: heparin regimen 1, 2000 U/h) in ten patients. These subjects were then given an infusion of prostacyclin, in the form of epoprostenol sodium salt (dialysis II: prostacyclin, 5 ng .cntdot. kg-1 .cntdot. min-1), followed by an infusion of prostacyclin and heparin (dialysis III: heparin regimen 2, 500 U/h). Absolute platelet count, in vitro platelet aggregation and plasma beta-thromboglobulin decreased during prostacyclin infusion. Haemodialysis neutropenia was improved by prostacyclin. The membrane sieving coefficient factor and ultrafiltration volume were not improved by prostacyclin alone (dialysis II). Prostacyclin together with heparin (dialysis III) showed, 60 minutes after the start, an unchanged sieving coefficient factor compared with that of heparin alone, while the ultrafiltration volume significantly (P < 0.001) improved. The results of this study confirm those of earlier studies and suggest that prostaglandin I2 together with low-dose heparin improve the biocompatibilty and efficiency of dialysis treatment.

(PDF 0-2 workdays service: $29.90)

Accession: 006206504

PMID: 3537544



Related references

Effects of different antithrombotic agents prostacyclin heparin cg 4203 on platelets and hemostasis during bicarbonate hemodialysis. Thrombosis Research (SUPPL 6): 145, 1986

Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin. Przeglad Lekarski 47(3): 328-331, 1990

Lipid behavior during hemodialysis using heparin and prostacyclin. Minerva Medica 83(12): 801-804, 1992

Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Blood 60(4): 924-929, 1982

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. New England Journal of Medicine 304(16): 934-939, 1981

Comparative effects of unfractionated heparin and enoxaparin on hemostasis during hemodialysis. Clinical & Investigative Medicine 19(4 SUPPL ): S66, 1996

Toxicity of plasma from hemodialysis patients treated with heparin or prostacyclin. Acta Medica Scandinavica 216(1): 93-100, 1984

Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature. Thrombosis Research 19(4-5): 719-723, 1980

Comparative study of heparin and low molecular weight heparin in hemodialysis for chronic renal failure. Presse Medicale 16(19): 955-958, 1987

Comparative study of low molecular weight heparin and unfractionated heparin in patients on maintenance hemodialysis. Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 86: 177-183, 1990